Beth Israel Deaconess Hospital — Boston, Massachusetts

Beth Israel Deaconess Hospital is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Beth Israel Deaconess Hospital has participated in 6 clinical trials.

Therapeutic areas: Lupus Nephritis, Extreme Prematurity, Viruria.

Sponsors: Novartis Pharmaceuticals, University of Washington, Changzheng-Cinkate.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Deaconess Hospital?

Beth Israel Deaconess Hospital has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Deaconess Hospital conducted?

Beth Israel Deaconess Hospital has 6 clinical trials on record. Their work covers Lupus Nephritis, Extreme Prematurity, Viruria.

Is Beth Israel Deaconess Hospital accredited by Crixeo Health?

Yes — Beth Israel Deaconess Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Beth Israel Deaconess Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.